Direct Down-scale Experiments of Concentration Column Designs for SHINE Process
- Argonne National Lab. (ANL), Argonne, IL (United States)
Argonne is assisting SHINE Medical Technologies in their efforts to become a domestic Mo-99 producer. The SHINE accelerator-driven process uses a uranyl-sulfate target solution for the production of fission-product Mo-99. Argonne has developed a molybdenum recovery and purification process for this target solution. The process includes an initial Mo recovery column followed by a concentration column to reduce the product volume from 15-25 L to < 1 L prior to entry into the LEU Modified Cintichem (LMC) process for purification.1 This report discusses direct down-scale experiments of the plant-scale concentration column design, where the effects of loading velocity and temperature were investigated.
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- USDOE National Nuclear Security Administration (NNSA), Office of Defense Nuclear Nonproliferation
- DOE Contract Number:
- AC02-06CH11357
- OSTI ID:
- 1372108
- Report Number(s):
- ANL/NE-17/11; 136065
- Country of Publication:
- United States
- Language:
- English
Similar Records
Recovery of Mo in LEU-Modified Cintichem Process at Elevated Mo Concentrations
SHINE and Mini-SHINE Column Designs for Recovery of Mo from 140 g-U/L Uranyl Sulfate
Compendium of Phase-I Mini-SHINE Experiments
Technical Report
·
Sun Sep 01 00:00:00 EDT 2019
·
OSTI ID:1372108
SHINE and Mini-SHINE Column Designs for Recovery of Mo from 140 g-U/L Uranyl Sulfate
Technical Report
·
Thu Sep 01 00:00:00 EDT 2016
·
OSTI ID:1372108
Compendium of Phase-I Mini-SHINE Experiments
Technical Report
·
Sat Oct 01 00:00:00 EDT 2016
·
OSTI ID:1372108
+20 more